Class IIOngoingD-0695-2026
Drug recall · July 8, 2026
TERPENICOL Antifungal Cream recall
Why: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
TERPENICOL Antifungal Cream (Undecylenic Acid 13%), 1.0 oz (28 g) bottles, Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Sante Fe Springs, CA 90670, NDC 63347-601-01.
- Lots / codes
Lots BL3431R, Exp Date 10/13/26 & BL3528, Exp Date 08/30/2027.
- Quantity
- 22,143 bottles
- Company
- Blaine Labs Inc, Santa Fe Springs, CA
- Distribution
- Nationwide in the USA
- Initiated
- April 8, 2026 · Voluntary: Firm initiated
- Classified
- July 16, 2026
- Reported
- July 8, 2026
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IOngoingJul 8, 2026Revitaderm Wound Care GelBlaine Labs Inc · D-0692-2026Class IIOngoingJul 8, 2026TRIFLUENT PHARMA TRIDERGEL Wound Care GelBlaine Labs Inc · D-0693-2026Class IIOngoingJul 8, 2026TRIPENICOL S Antifungal SolutionBlaine Labs Inc · D-0694-2026Class IIOngoingJul 8, 2026vite20 Antifungal CreamBlaine Labs Inc · D-0696-2026Class IIOngoingJul 8, 2026TERPENICOL Antifungal SolutionBlaine Labs Inc · D-0697-2026Class IIOngoingJul 8, 2026Fungal Fusion ERADICATION SolutionBlaine Labs Inc · D-0698-2026Class IIOngoingJul 8, 2026Revitaderm Wound CareBlaine Labs Inc · D-0699-2026
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.